GRANT SUPPORT

 

Current grant support 

 

Title: Fusion of disseminated tumor cells with HSCs facilitates prostate cancer skeletal metastasis 

Role in Project: PI

Source of Funds: National NSF Project, China

Direct cost: Total: 510,000

Support Period: 1/1/2018-12/31/2021

 

Title: Key technology and biomarkers of lung cancer early diagnosis

Role in Project: PI

Source of Funds: Shenzhen science and Technology Innovation Committee, Shenzhen, Guangdong, China

Direct cost: Total: 2,000,000

Support Period: 7/1/2017-6/30/2020

 

Title: Molecular mechanisms of chemokine and chemokine receptor (CCL2/CCR2) axis in NPC growth and metastasis

Role in Project: PI

Source of Funds: Shenzhen science and Technology Innovation Committee, Shenzhen, Guangdong, China

Direct cost: Total: 400,000

Support Period: 7/1/2017-6/30/2019

 

Title: Protein Networks on DTCs activation in prostate cancer

Role in Project: PI

Source of Funds: National NSF Project, China

Direct cost: Total: 700,000

Support Period: 1/1/2013-12/31/2016

 

Title: Center grant for the Key Laboratory of Longevity and Ageing-related Diseases, Ministry of Education, China

Role in Project: Co-I

Direct cost: Total: 4,000,000

Source of Funds: National Key Laboratory funding from Guangxi, China

Support Period: 1/1/2012-12/31/2016

 

 

Completed other research grants

 

National NSF Project: Molecular mechanisms of host-derived CCL2 in prostate cancer skeletal metastasis, PI,  1/1/2012-12/31/2015.

National NSF Key Project: Protein Networks on EMT-mediated chemoresistance in prostate cancer, Co-I, 1/1/2012-12/31/2016.

Guangxi NSF project: Mechanisms of CCL2/CCR2 axis in NPC growth and development, PI, 4/1/2012-12/31/2015.

Project of Ministry of Education, Guangxi: Novel serum biomarkers in NPC skeletal metastasis, Co-I, 1/1/2012-12/31/2013.

Tianjin NSF Project: MCP-1/CCR2 signaling in breast cancer development. PI, 10/2007-10/2010.

973 Key Project: Mechanisms of Cell Adhesion Molecules (CAMs) and their receptors signaling in Tumor growth and metastasis. Main Participant, 1/2009-12/2013

Department of Defense (DOD): Inhibition of prostate cancer skeletal metastases by targeting cathepsin K. Main Participant, 4/2007-4/2011

Copyright © 2018 All Rights Reserved.